The CRO sector declined at the beginning of the market. Jinkai Biotech fell more than 10%, while Hongbo Pharmaceuticals, Tiger Pharmaceuticals, Nootai Biotech, Gloria, and Pharmaceutical Stone Technology followed suit.

The CRO sector declined at the beginning of the market. Jinkai Biotech fell more than 10%, while Hongbo Pharmaceuticals, Tiger Pharmaceuticals, Nootai Biotech, Gloria, and Pharmaceutical Stone Technology followed suit.

Zhitong FinanceApr 24 09:41

Hongbo Pharmaceutical (301230.SZ) announced its 2023 annual results, with net profit of 376.192 million yuan, a year-on-year decrease of 44%

Hongbo Pharmaceutical (301230.SZ) announced its 2023 annual results. The company achieved operating income of 4.9 during the period...

Zhitong FinanceApr 23 20:47

Express News | Since April, nearly 10 listed companies have announced illegal short-term transactions involving senior directors and supervisors

BreakingsApr 14 19:49

The A-share CRO concept changed and increased, with Punitest rising by nearly 5%, while Tailong Pharmaceutical, Hongbo Pharmaceutical, Haite Biotech, and Blue Biotech followed suit

The A-share CRO concept changed and increased, with Punitest rising by nearly 5%, while Tailong Pharmaceutical, Hongbo Pharmaceutical, Haite Biotech, and Blue Biotech followed suit

Zhitong FinanceApr 11 10:17

Hongbo Pharmaceutical (301230.SZ): A total cost of 178.587 million yuan to buy back 0.5847% of the shares

Gelonghui, April 1, 丨 Hongbo Pharmaceutical (301230.SZ) announced that as of March 31, 2024, the company had repurchased a total of 629,300 shares through a dedicated securities account, accounting for 0.5847% of the company's current total share capital of 107,622,666 shares. The highest transaction price was 37.68 yuan/share, and the lowest transaction price was 26.82 yuan/share. The total transaction amount was 17,858,707.12 yuan (excluding transaction fees).

Gelonghui FinanceApr 1 20:11

A-shares CRO concept stocks fluctuated and declined

Gelonghui, March 21 | Hongbo Pharmaceutical and Chengdu Pioneer fell more than 4%, while many stocks such as Medici, Wisdom Pharmaceutical, and Wanbang Pharmaceutical fell.

Gelonghui FinanceMar 21 10:15